Major hepatic resection for neoplasia: personal experience in 108 patients.

PubWeight™: 2.80‹?› | Rank: Top 1%

🔗 View Article (PMC 1396969)

Published in Ann Surg on September 01, 1978

Authors

J G Fortner, D K Kim, B J Maclean, M K Barrett, S Iwatsuki, A D Turnbull, W S Howland, E J Beattie

Articles citing this

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Experience with 150 liver resections. Ann Surg (1983) 3.01

Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59

Major hepatic resection. A 25-year experience. Ann Surg (1983) 2.55

Major hepatic resections for metastatic colorectal cancer. Ann Surg (1980) 2.41

Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg (1984) 2.07

Major hepatic resection for metachronous metastases from colon cancer. Ann Surg (1985) 1.89

Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83

Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. J Am Coll Surg (2014) 1.76

Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) (2010) 1.51

Studies on the treatment and prevention of colorectal liver metastases. Ann R Coll Surg Engl (1981) 1.49

Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg (2011) 1.29

Surgical resection for benign and malignant liver disease. Ann Surg (1980) 1.22

Intraperitoneal septic complications after hepatectomy. Ann Surg (1986) 1.22

Hepatic resection for metastatic cancer. Ann Surg (1984) 1.21

Intra-abdominal sepsis after hepatic resection. Ann Surg (1989) 1.07

Hepatic resection in the elderly. Ann Surg (1990) 1.07

Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB (Oxford) (2005) 1.04

Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg (1987) 1.01

Hepatic metastases from soft-tissue sarcoma. Ann Surg (1995) 0.96

Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Korean J Radiol (2003) 0.88

Liver resection for hepatocellular carcinoma: results from 150 consecutive patients. Cancer Chemother Pharmacol (1989) 0.87

Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol (1992) 0.86

Water-soluble ethylhydroxyethyl cellulose prevents bacterial translocation induced by major liver resection in the rat. Ann Surg (1993) 0.84

Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection. Ann Surg (2000) 0.81

A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case. Surg Today (2013) 0.80

Screening for hepatocellular carcinoma. Review and perspective. West J Med (1988) 0.80

Hepatic arterial chemotherapy for primary and metastatic liver cancers. Cancer Chemother Pharmacol (1989) 0.76

Mortality and survival rates after elective hepatic surgery in a low-volume centre are comparable to those of high-volume centres. ISRN Surg (2012) 0.75

Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality. World J Gastroenterol (2014) 0.75

Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. Medicine (Baltimore) (2016) 0.75

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Hepatic Retransplantation. Transplant Proc (1985) 3.62

The epidemiology of lung cancer. Recent trends. JAMA (1970) 3.53

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

Experience with 150 liver resections. Ann Surg (1983) 3.01

Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol (2000) 2.96

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91

Liver transplantation in adults. Hepatology (1982) 2.89

Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80

Giant hemangiomas of the liver. Ann Surg (1970) 2.70

Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63

Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet (1985) 2.59

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49

Regional resection of cancer of the pancreas: a new surgical approach. Surgery (1973) 2.43

Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet (1982) 2.42

Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta (2001) 2.41

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci U S A (2000) 2.41

Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39

Liver transplantation across ABO blood groups. Surgery (1986) 2.39

Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37

Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol (1998) 2.33

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg (1975) 2.31

Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30

Malignant schwannoma. A clinicopathologic study. Cancer (1973) 2.26

Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20

Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis (1985) 2.16

A growth factor in fine vascular anastomoses. Surg Gynecol Obstet (1984) 2.15

Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11

A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis (1986) 2.09

Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07

Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics (1986) 2.04

Malignant schwannoma--clinical characteristics, survival, and response to therapy. Cancer (1981) 2.04

Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03

Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc (1985) 1.98

Elderly applicants to long-term care institutions. I. Their characteristics, health problems and state of mind. J Am Geriatr Soc (1976) 1.96

Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg (1977) 1.96

Liver transplantation against T cell-positive warm crossmatches. Transplant Proc (1984) 1.96

The continuing challenge of retroperitoneal sarcomas. Cancer (1981) 1.95

Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92

Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91

Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89

The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87

Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics (1984) 1.86

Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med (1973) 1.85

Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg (1982) 1.84

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer (2000) 1.82

Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis (1990) 1.82

FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH. Mol Cell (2000) 1.82

Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries. J Am Coll Surg (1994) 1.81

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80

Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77

Current status of hepatic transplantation. Semin Liver Dis (1983) 1.75

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg (1996) 1.74

Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73

Retransplantation of the liver. Semin Liver Dis (1985) 1.73

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72